菜单

Supply Chain Intelligence about:

Zhejiang Huahai Pharmaceutical Co.

企业页面   China

See Zhejiang Huahai Pharmaceutical Co.'s products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

2,468美国进口货运
US
240 南美货运信息
南美

以公司为组织的美国海关记录

2,468 U.S. shipments available for Zhejiang Huahai Pharmaceutical Co., updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2023-04-20 Zhejiang Huahai Pharmaceutical Co.
Solco Healthcare US Llc
XXXXXXXXX XXXXXXXXXXXXX XXXXXXXXXXXXXXXX XXXX XXX
货运提单
2023-04-19 Zhejiang Huahai Pharmaceutical Co.
Solco Healthcare US Llc
XXXXXXXXXXXX XXXXXXX
货运提单
2023-04-19 Zhejiang Huahai Pharmaceutical Co.
Solco Healthcare US Llc
XXXXXXXXXX XXXXXXXXX XXX XXXXXXXXXXXXXXXXXXX XXXXXXX XXXXXXXXXXX XXXXXXX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data


Sample Bill of Lading

7,719 shipment records available

Date
2023-04-20
Shipper Name
Zhejiang Huahai Pharmaceutical Co.
Shipper Address
XUNQIAO LINHAI ZHEJIANG 317024
Consignee Name
Solco Healthcare Us, Llc
Consignee Address
SOMERSET NJ 08873 USA SOMERSET NJ 08873 US
Weight
6266
Weight Unit
KG
Weight in KG
6266.0
Quantity
21
Quantity Unit
PKG
Measure Unit
CM
Shipment Origin
China
Details
6,266.0 kg
From port: Ningbo, China
To port: Georgia Ports Authority, Savannah, Georgia
Place of Receipt
Ningbo
Foreign Port of Lading
Ningbo, China
U.S. Port of Unlading
Georgia Ports Authority, Savannah, Georgia
U.S. Destination Port
Georgia Ports Authority, Savannah, Georgia
Commodity
XXXXXXXXX XXXXXXXXXXXXX XXXXXXXXXXXXXXXX XXXX XXX
Container
FSCU5319068
Carrier Name
DSV OCEAN TRANSPORT A/S
Vessel Name
COSCO SHIPPING JASMINE
Voyage Number
021E
Bill of Lading Number
DFDSSHP7009925
Master Bill of Lading Number
OOLU2139249230
Lloyd's Code
9785768
HTS Codes
HTS 3004.90

Recent Panjiva Research about Zhejiang Huahai Pharmaceutical Co.

20161216-anticonvulsants-total-1

Drug Misuse Rule Changes Visible in AC Trade Data

Yet, within the class, imports of gabapentin (generic Neurontin) dropped 18%. This may be linked to new reporting requirements relating to misuse of the drug as a painkiller. That change may have driven a switch to generic versions of GSK’s Lamotrigine and UCB’s Keppra which both reached recor... Read more →